(-)-epigallocatechin 3-gallate multiple interactions ISO RASL11A (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RASL11A mRNA CTD PMID:22079256 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of RASL11A mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RASL11A (Homo sapiens) 6480464 Estradiol results in increased expression of RASL11A mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RASL11A mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Rasl11a (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of RASL11A mRNA CTD PMID:33387578 and PMID:34747641 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Rasl11a (Rattus norvegicus) 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of RASL11A mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RASL11A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASL11A mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RASL11A mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of RASL11A mRNA CTD PMID:28973697 9-cis-retinoic acid increases expression ISO Rasl11a (Rattus norvegicus) 6480464 Alitretinoin results in increased expression of RASL11A mRNA CTD PMID:16648578 acrylamide increases expression ISO RASL11A (Homo sapiens) 6480464 Acrylamide results in increased expression of RASL11A mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RASL11A (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of RASL11A exon CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RASL11A (Homo sapiens) 6480464 Tretinoin results in increased expression of RASL11A mRNA CTD PMID:23830798 all-trans-retinoic acid decreases expression ISO RASL11A (Homo sapiens) 6480464 Tretinoin results in decreased expression of RASL11A mRNA CTD PMID:33167477 aristolochic acid A increases expression ISO RASL11A (Homo sapiens) 6480464 aristolochic acid I results in increased expression of RASL11A mRNA CTD PMID:33212167 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression ISO RASL11A (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of RASL11A mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of RASL11A 3' UTR and Benzo(a)pyrene results in decreased methylation of RASL11A exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RASL11A (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of RASL11A exon CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RASL11A (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of RASL11A promoter CTD PMID:27901495 benzo[b]fluoranthene decreases expression EXP 6480464 benzo(b)fluoranthene results in decreased expression of RASL11A mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA CTD PMID:27858113 bexarotene increases expression ISO Rasl11a (Rattus norvegicus) 6480464 bexarotene results in increased expression of RASL11A mRNA CTD PMID:16648578 bisphenol A multiple interactions ISO RASL11A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASL11A mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RASL11A mRNA CTD PMID:32156529 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RASL11A mRNA CTD PMID:35479511 bisphenol F multiple interactions ISO RASL11A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RASL11A mRNA CTD PMID:28628672 calcidiol decreases expression ISO Rasl11a (Rattus norvegicus) 6480464 Calcifediol deficiency results in decreased expression of RASL11A mRNA CTD PMID:17293106 calcitriol decreases expression ISO RASL11A (Homo sapiens) 6480464 Calcitriol results in decreased expression of RASL11A mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RASL11A (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RASL11A mRNA CTD PMID:21592394 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RASL11A (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to RASL11A gene] CTD PMID:28238834 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of RASL11A mRNA CTD PMID:23125180 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASL11A mRNA CTD PMID:20938992 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA CTD PMID:27858113 cisplatin increases expression ISO RASL11A (Homo sapiens) 6480464 Cisplatin results in increased expression of RASL11A mRNA CTD PMID:27392435 cocaine increases expression ISO Rasl11a (Rattus norvegicus) 6480464 Cocaine results in increased expression of RASL11A mRNA CTD PMID:27899881 copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11A mRNA CTD PMID:15467011 copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11A mRNA CTD PMID:15467011 crocidolite asbestos affects expression ISO RASL11A (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of RASL11A mRNA CTD PMID:25757056 dexamethasone increases expression ISO RASL11A (Homo sapiens) 6480464 Dexamethasone results in increased expression of RASL11A mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RASL11A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASL11A mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RASL11A mRNA CTD PMID:28628672 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of RASL11A mRNA CTD PMID:21266533 dimethylarsinic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA CTD PMID:34876320 endosulfan affects expression ISO Rasl11a (Rattus norvegicus) 6480464 Endosulfan affects the expression of RASL11A mRNA CTD PMID:29391264 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASL11A mRNA CTD PMID:20938992 furan increases methylation ISO Rasl11a (Rattus norvegicus) 6480464 furan results in increased methylation of RASL11A gene CTD PMID:22079235 gentamycin decreases expression ISO Rasl11a (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of RASL11A mRNA CTD PMID:33387578 glycidol decreases expression ISO Rasl11a (Rattus norvegicus) 6480464 glycidol results in decreased expression of RASL11A mRNA CTD PMID:24915197 indometacin multiple interactions ISO RASL11A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RASL11A mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RASL11A mRNA CTD PMID:28628672 ketamine increases expression ISO Rasl11a (Rattus norvegicus) 6480464 Ketamine results in increased expression of RASL11A mRNA CTD PMID:20080153 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RASL11A mRNA CTD PMID:20938992 lead(0) decreases expression ISO RASL11A (Homo sapiens) 6480464 Lead results in decreased expression of RASL11A mRNA CTD PMID:19921347 Licochalcone B increases expression ISO RASL11A (Homo sapiens) 6480464 licochalcone B results in increased expression of RASL11A mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO RASL11A (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of RASL11A mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RASL11A (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 manganese(II) chloride decreases expression ISO Rasl11a (Rattus norvegicus) 6480464 manganese chloride results in decreased expression of RASL11A mRNA CTD PMID:28801915 menadione affects expression ISO RASL11A (Homo sapiens) 6480464 Vitamin K 3 affects the expression of RASL11A mRNA CTD PMID:20044591 methamphetamine increases expression ISO Rasl11a (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of RASL11A mRNA CTD PMID:19564919 methamphetamine multiple interactions ISO Rasl11a (Rattus norvegicus) 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of RASL11A mRNA CTD PMID:19564919 methylarsonic acid multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA CTD PMID:34876320 methylisothiazolinone increases expression ISO RASL11A (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of RASL11A mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RASL11A (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of RASL11A mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium decreases expression ISO Rasl11a (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of RASL11A mRNA CTD PMID:28801915 O-methyleugenol decreases expression ISO RASL11A (Homo sapiens) 6480464 methyleugenol results in decreased expression of RASL11A mRNA CTD PMID:32234424 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RASL11A mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RASL11A mRNA CTD PMID:34911549 paracetamol decreases expression ISO Rasl11a (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of RASL11A mRNA CTD PMID:33387578 perfluorohexanesulfonic acid increases expression ISO RASL11A (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in increased expression of RASL11A mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO RASL11A (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of RASL11A mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid increases expression ISO RASL11A (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of RASL11A mRNA CTD PMID:25812627 potassium chromate multiple interactions ISO RASL11A (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RASL11A mRNA CTD PMID:22079256 potassium chromate increases expression ISO RASL11A (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of RASL11A mRNA CTD PMID:22079256 progesterone increases expression ISO RASL11A (Homo sapiens) 6480464 Progesterone results in increased expression of RASL11A mRNA CTD PMID:20864642 rotenone increases expression EXP 6480464 Rotenone results in increased expression of RASL11A mRNA CTD PMID:32937126 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RASL11A (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 SCH 23390 multiple interactions ISO Rasl11a (Rattus norvegicus) 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of RASL11A mRNA CTD PMID:19564919 sodium arsenate multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RASL11A (Homo sapiens) 6480464 sodium arsenite results in decreased expression of RASL11A mRNA CTD PMID:29301061 sodium arsenite multiple interactions EXP 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RASL11A mRNA CTD PMID:34876320 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of RASL11A mRNA CTD PMID:37682722 sotorasib multiple interactions ISO RASL11A (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RASL11A mRNA CTD PMID:36139627 sulforaphane decreases expression ISO RASL11A (Homo sapiens) 6480464 sulforaphane results in decreased expression of RASL11A mRNA CTD PMID:31838189 sunitinib decreases expression ISO RASL11A (Homo sapiens) 6480464 Sunitinib results in decreased expression of RASL11A mRNA CTD PMID:31533062 testosterone decreases expression ISO RASL11A (Homo sapiens) 6480464 Testosterone results in decreased expression of RASL11A mRNA CTD PMID:21592394 testosterone multiple interactions ISO RASL11A (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RASL11A mRNA CTD PMID:21592394 tetraphene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RASL11A mRNA CTD PMID:27858113 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of RASL11A mRNA CTD PMID:27760801 titanium dioxide decreases expression ISO Rasl11a (Rattus norvegicus) 6480464 titanium dioxide results in decreased expression of RASL11A mRNA CTD PMID:30012374 trametinib multiple interactions ISO RASL11A (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RASL11A mRNA CTD PMID:36139627 tunicamycin decreases expression ISO RASL11A (Homo sapiens) 6480464 Tunicamycin results in decreased expression of RASL11A mRNA CTD PMID:29453283